(Q34999764)

English

Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Escitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

ChEBI release 2020-05-28

object named as

K Brosen

6

0 references

object named as

P Damkier

5

0 references

author name string

L Noehr-Jensen

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

S T Zwisler

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

F Larsen

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

S H Sindrup

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

26 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

626-633

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

https://scigraph.springernature.com/pub.10.1038/clpt.2009.154

0 references

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Inhibitors of imipramine metabolism by human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Depression and pain comorbidity: a literature review

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Antidepressants: prevalence of duplicate therapy and avoidable drug interactions in Australian veterans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Impact of CYP2D6 genotype on postoperative tramadol analgesia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

The analgesic effect of codeine as compared to imipramine in different human experimental pain models

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Morphine and ibuprofen compared using the cold pressor test

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

The effects of tramadol on static and dynamic pupillometry in healthy subjects--the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Clinical pharmacology of tramadol

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

21 January 2018

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

The hypoalgesic effect of tramadol in relation to CYP2D6*

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

Instrumental assessment of psychomotor functions and the effects of psychotropic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

Enantioselective HPLC method for quantitative determination of tramadol andO-desmethyltramadol in plasma and urine: Application to clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

Linear mixed effects models

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.154

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2009.154

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34999764&oldid=1961989538"